Healthcare

AstraZeneca and Oracle partner on AI-enabled healthcare innovation

AstraZeneca and Oracle are testing AI tools to identify eligible patients earlier and accelerate evidence generation, with an initial Abu Dhabi hypertension project involving M42.

The UAE is serving as the initial regional setting for a multinational collaboration between AstraZeneca and Oracle. The program will use real-world data and AI-enabled applications to help care teams identify patients earlier, improve treatment pathways, and recruit appropriate participants for clinical studies. M42 is involved in the Abu Dhabi hypertension project, which is designed to support patients with uncontrolled blood pressure. The companies also plan to examine drug-safety monitoring and evidence generation across the lifecycle of medicines. The development demonstrates how Gulf healthcare organizations are becoming test environments for integrated AI applications spanning providers, pharmaceutical research, and cloud technology.

Original source: Ground News

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI